Wave Life Sciences (WVE) stock, explained like you're 5

Is Wave Life Sciences a small, medium or large cap company?

No. Wave Life Sciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 682 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Wave Life Sciences makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves WVE stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Wave Life Sciences (WVE) Stock Fair Value Moves Lower As Analysts Cut Growth Views (Yahoo Finance)
• UBS upgrades Wave Life Sciences stock as October 20 panel nears (ad-hoc-news.de)
• A biotech CEO is scheduled to discuss medicines that use RNA in New York on Oct. 20. (Stock Titan)
• William Blair initiates Wave Life Sciences stock with outperform rating By Investing.com (Investing.com Nigeria)
• Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales (Simply Wall Street)

Key terms to know before you follow WVE

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility